Market Research Logo

Solid Tumor Testing Market in the US 2018-2022

Solid Tumor Testing Market in the US 2018-2022

About Solid Tumor Testing

Solid tumor testing is a medical procedure that helps in the early detection of cancer. It is done to avoid the spread of cancerous cells throughout the body and allow for effective treatment.

Technavio’s analysts forecast the solid tumor testing market in the US to grow at a CAGR of 10.72% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the solid tumor testing market in the US for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.Technavio's report, Solid Tumor Testing Market in the US 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Agilent Technologies
  • Becton, Dickinson and Company
  • Danaher
  • F. Hoffmann-La Roche
  • Illumina
  • Thermo Fisher Scientific
Market driver
  • Growing prevalence of cancer
  • For a full, detailed list, view our report
Market challenge
  • High cost of sequencing
  • For a full, detailed list, view our report
Market trend
  • Adoption of NGS in cancer diagnostics
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Solid Tumor Testing Market in the US 2018-2022

Technavio recognizes the following companies as the key players in the solid tumor testing market in the US: Agilent Technologies, Becton, Dickinson and Company, Danaher, F. Hoffmann-La Roche, Illumina, and Thermo Fisher Scientific.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is adoption of NGS in cancer diagnostics. The growing adoption of NGS in cancer diagnostics is identified to be one of the key trends driving the growth of the solid tumor testing market in the US. Next-generation sequencing (NGS) is a high-throughput methodology that enables rapid sequencing of the base pairs in DNA or RNA samples.”

According to the report, one driver in the market is growing prevalence of cancer. Globally, cancer is the primary cause for the high mortality rates among all age groups. In 2014, 1.6 million new cancer cases were diagnosed out of which 600,000 individuals succumbed to the disease. Many types of cancer are curable if diagnosed at early stage, however, few are fatal.

Further, the report states that one challenge in the market is high cost of sequencing. As sequencing involves the handling of high throughput data, the maintenance of precision and accuracy requires highly skilled personnel and cutting-edge technology and equipment. Thus, setting up a laboratory consumes a significant amount of capital.

Companies Mentioned

Agilent Technologies
Becton, Dickinson and Company
Danaher
F. Hoffmann-La Roche
Illumina
Thermo Fisher Scientific

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Related market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Solid tumor testing market in the US- Market size and forecast 2017-2022 ($ bn)
      • Table Solid tumor testing market in the US - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017 and 2022
  • Market segmentation by technology
    • Segmentation by technology
      • Table Solid tumor testing market in the US by technology - Market share 2017-2022 (%)
    • Comparison by technology
      • Table Comparison by technology
    • Conventional testing - Market size and forecast 2017-2022
      • Table Conventional tests for solid tumors associated with various types of cancer
      • Table Conventional testing - Market size and forecast 2017-2022 ($ bn)
      • Table Conventional testing - Year over year growth 2018-2022 (%)
    • Non-conventional testing - Market size and forecast 2017-2022
      • Table Non-conventional testing - Market size and forecast 2017-2022 ($ bn)
      • Table Non-conventional testing - Year over year growth 2018-2022 (%)
    • Market opportunity by technology
      • Table Market opportunity by technology
  • Customer landscape
    • Table Customer landscape
  • Segmentation by end-user
    • Table Solid tumor testing market in the US by end-user - Market share 2017-2022 (%)
    • Comparison by end-user
      • Table Comparison by end-user
    • Hospitals - Market size and forecast 2017-2022
      • Table Hospitals - Market size and forecast 2017-2022 ($ bn)
      • Table Hospitals - Year over year growth 2018-2022 (%)
    • Diagnostic laboratories - Market size and forecast 2017-2022
      • Table Diagnostic laboratories - Market size and forecast 2017-2022 ($ bn)
      • Table Diagnostic laboratories - Year over year growth 2018-2022 (%)
    • Academic and research institutes - Market size and forecast 2017-2022
      • Table R&D funding for cancer 2013-2016 ($ millions)
      • Table Academic and research institutes- Market size and forecast 2017-2022 ($ bn)
      • Table Academic and research institutes - Year over year growth 2018-2022 (%)
    • Market opportunity by end-user
      • Table Market opportunity by end-user
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Adoption of NGS in cancer diagnostics
      • Table Cost of sequencing per genome 2001-2015 ($)
    • Preference for liquid biopsy over traditional biopsy
    • Increase in investment in cancer research
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Agilent Technologies
      • Table Agilent Technologies overview
      • Table Agilent Technologies- Business segments
      • Table Agilent Technologies - Organizational developments
      • Table Agilent Technologies - Geographic focus
      • Table Agilent Technologies - Segment focus
      • Table Agilent Technologies - Key offerings
    • Becton, Dickinson and Company
      • Table Becton, Dickinson and Company overview
      • Table Becton, Dickinson and Company - Business segments
      • Table Becton, Dickinson and Company - Organizational developments
      • Table Becton, Dickinson and Company - Geographic focus
      • Table Becton, Dickinson and Company - Segment focus
      • Table Becton, Dickinson and Company - Key offerings
    • Danaher
      • Table Danaher overview
      • Table Danaher - Business segments
      • Table Danaher - Organizational developments
      • Table Danaher- Geographic focus
      • Table Danaher- Segment focus
      • Table Danaher - Key offerings
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche overview
      • Table F. Hoffmann-La Roche- Business segments
      • Table F. Hoffmann-La Roche - Organizational developments
      • Table F. Hoffmann-La Roche- Geographic focus
      • Table F. Hoffmann-La Roche- Segment focus
      • Table F. Hoffmann-La Roche - Key offerings
    • Illumina
      • Table Illumina overview
      • Table Illumina - Business segments
      • Table Illumina - Organizational developments
      • Table Illumina - Geographic focus
      • Table Illumina - Segment focus
      • Table Illumina - Key offerings
    • Thermo Fisher Scientific
      • Table Thermo Fisher Scientific overview
      • Table Thermo Fisher Scientific- Business segments
      • Table Thermo Fisher Scientific- Organizational developments
      • Table Thermo Fisher Scientific- Geographic focus
      • Table Thermo Fisher Scientific- Segment focus
      • Table Thermo Fisher Scientific- Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report